Commodore Capital’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$157M Sell
3,000,000
-1,200,000
-29% -$46.9M 9.36% 3
2026
Q1
$149M Buy
4,200,000
+650,000
+18% +$20.2M 8.59% 2
2025
Q4
$99.3M Buy
3,550,000
+453,246
+15% +$13.6M 6.61% 2
2025
Q3
$92.9M Buy
3,096,754
+646,754
+26% +$18.2M 4.54% 7
2025
Q2
$70.1M Buy
2,450,000
+500,000
+26% +$14.9M 4.95% 7
2025
Q1
$64.4M Sell
1,950,000
-350,000
-15% -$11.4M 4.74% 6
2024
Q4
$66.1M Sell
2,300,000
-600,000
-21% -$17.2M 4.85% 8
2024
Q3
$81.2M Buy
2,900,000
+1,525,000
+111% +$40.7M 5.07% 8
2024
Q2
$33.1M Buy
+1,375,000
New +$33.7M 2.26% 16

Other funds holding ALKS

Commodore Capital's ALKS Position: Q2 2026 in Review

Commodore Capital reduced its Alkermes (ALKS) stake by 29% in Q2 2026, selling an estimated $46.9M and leaving 3,000,000 shares worth $157M. The position accounts for 9.36% of the portfolio, ranked #3.

Commodore Capital first reported a position in ALKS in Q2 2024 and has held it in 9 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Commodore Capital held 3,000,000 shares of Alkermes worth $157M as of Q2 2026.
  • Commodore Capital sold 1,200,000 Alkermes shares in Q2 2026, an estimated $46.9M.
  • Alkermes made up 9.36% of Commodore Capital's portfolio in Q2 2026, its #3 holding.
  • Commodore Capital first reported a position in Alkermes in Q2 2024 and has held it in 9 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Commodore Capital's 13F filing for Q2 2026, filed 14 Aug 2026.